Epigenomics AG (EPGNF)
1.12
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Epigenomics Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.083M |
| March 31, 2023 | 4.936M |
| December 31, 2022 | 10.86M |
| September 30, 2022 | 13.65M |
| June 30, 2022 | 17.42M |
| March 31, 2022 | 21.24M |
| December 31, 2021 | 25.15M |
| September 30, 2021 | 28.09M |
| June 30, 2021 | 7.544M |
| March 31, 2021 | 7.615M |
| December 31, 2020 | 4.728M |
| September 30, 2020 | 6.501M |
| June 30, 2020 | 8.218M |
| March 31, 2020 | 6.882M |
| December 31, 2019 | 10.81M |
| September 30, 2019 | 9.73M |
| June 30, 2019 | 13.33M |
| March 31, 2019 | 17.72M |
| December 31, 2018 | 21.28M |
| September 30, 2018 | 2.761M |
| June 30, 2018 | 5.884M |
| March 31, 2018 | 9.452M |
| December 31, 2017 | 12.70M |
| September 30, 2017 | 15.37M |
| June 30, 2017 | 9.660M |
| Date | Value |
|---|---|
| March 31, 2017 | 13.12M |
| December 31, 2016 | 15.21M |
| September 30, 2016 | 7.697M |
| June 30, 2016 | 10.27M |
| March 31, 2016 | 5.893M |
| December 31, 2015 | 7.711M |
| September 30, 2015 | 8.256M |
| June 30, 2015 | 9.644M |
| March 31, 2015 | 4.694M |
| December 31, 2014 | 7.391M |
| September 30, 2014 | 3.821M |
| June 30, 2014 | 6.744M |
| March 31, 2014 | 9.300M |
| December 31, 2013 | 8.900M |
| September 30, 2013 | 5.159M |
| June 30, 2013 | 6.972M |
| March 31, 2013 | 8.942M |
| December 31, 2012 | 5.482M |
| September 30, 2012 | 8.906M |
| June 30, 2012 | 13.50M |
| March 31, 2012 | 18.66M |
| December 31, 2011 | 21.01M |
| September 30, 2011 | 27.67M |
| June 30, 2011 | 37.10M |
| March 31, 2011 | 40.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CureVac NV | 1.024B |
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |